Peters Surgical Group.
At Peters Surgical, we aim to improve patient’s quality of care by contributing to the success of surgical procedures. We develop high-performance medical devices and dedicated services with and for surgical teams.
Innovation
From R&D to Open Innovation.
Peters Surgical has a long history of innovation. With over 50 patents, a solid financial investment to support Innovations and a team of 10+ Engineers working every day to provide new technologies. Innovation is definitely in our DNA.
Building scientific partnerships in the medical community.
Since the very beginning of the company, we have built a network of trust and created scientific partnerships with the medical community.
For years, we have been working in close collaboration with academic societies, prestigious Research hospitals, such as Hospital Virtuel de
Lorraine (Nancy) and CICE (Clermont-Ferrand).
As an agile company, we work in a collaborative and proactive mode with
the all communities, creating an ecosystem that gathers healthcare professionals, research laboratories as well as start-ups.
Submit your project >
International
With over 765 employees worldwide, 6 manufacturing sites in France, Germany (2), India,
Algeria & Thailand, Peters Surgical is providing healthcare solutions in over 90
countries. +70% of our sales are generated internationally.
Local Hubs for Local Needs.
Every healthcare provider, every partner are different, and so are their needs. To be more reactive and closer to our partners and local customers, we have created local hubs in Americas, France, Europe (Western/Eastern) &
Middle East, Africa-India and Asia-Pacific.
With manufacturing facilities in key geographies, France, Germany (2), Algeria, India and Thailand, we ensure the best standards in product quality, availability and delivery. Highly flexible and integrated, our production sites can support a 50% growth in volume while maintaining high quality standards.
Thanks to local commercial and industrial presence, we adapt each day a little more to the reality of the field, ajusting each of our decision-making to ensure optimal support.
CSR
Corporate Social Responsability
Community Involvement.
Our CSR initiatives are focused on project where we live and work that supports community in needs and improve education within our teams.
Environmental Impact.
As a global company, we are changing our process in order to reduce energy consumptions and limit environmental impact. Over the past 4 years, we have downsized our CO2 emissions by – 1,7kt.
Circular Economy.
Increasing opportunity for circular economy. We have initiated a CSR Audit of all our suppliers.
Executive Committee
Thierry HERBRETEAU
Group CEO
Marie COMPAGNON-RIOBÉ
Senior Director
Regulatory Affairs & Quality
Rachel CROPSAL
Senior Director
Sales & Marketing EMEL
Rajdeep DAS
CEO
Peters Surgical India
Bruno de LACROIX
Vice-President
International Sales
Dominique DELAMARE
COO
Marie-line GIRARD
Vice-President
Global Industrial
Ellen KNUPP
CEO
Peters Surgical US
Nathalie MIGNEROT
Vice-President Sales France, Benelux & Canada
Clémentine MOUGIN
Senior Director
Marketing HQ
Pierre PETIT
Senior Director
France Industry
Ines RIEDEL
CEO Peters Surgical Deutschland
Laurence SAFONT
CFO
Our History
The company took a historic step forward by collaborating for almost 10 years
with Prof. Alain Carpentier, calls the father of modern mitral valve repair, with
whom the company developed a full range of cardiovascular sutures.
1985
With a new CEO, Thierry Herbreteau, the company has embarked in a challenging
5-year strategy plan aimed at doubling its sales by 2023. This strategy is
supported by a global transformation of the company to refocus on customers
first, a revamping of its innovation and through acceleration and
internationalization.
2018
1926
The story of Peters Surgical begins in 1926. The company first produced probes and then quickly expanded to surgical sutures.
2013
In 2013, Peters Surgical completed a LBO with Eurazeo. In 5 years, the company
realized major acquisition: Fimed & Vitalitec, Stericat and Vectec, to focus on 5
strategic ranges: Sutures, Clips/VTO, Mesh, Surgical Glue and Laparoscopic0
Instruments.
1926
The story of Peters Surgical begins in 1926 with the two Peters brothers. They
first produced probes. The company quickly expanded to surgical sutures.
1985
The company took a historic step forward by collaborating for almost 10 years
with Prof. Alain Carpentier, calls the father of modern mitral valve repair, with
whom the company developed a full range of cardiovascular sutures.
2013
In 2013, Peters Surgical completed a LBO with Eurazeo. In 5 years, the company
realized major acquisition: Fimed & Vitalitec, Stericat and Vectec, to focus on 5
strategic ranges: Sutures, Clips/VTO, Meshes, Surgical Glue and Laparoscopic
Instruments.
2018
With a new CEO, Thierry Herbreteau, the company has embarked in a challenging
5-year strategy plan aimed at doubling its sales by 2023. This strategy is
supported by a global transformation of the company to refocus on customers
first, a revamping of its innovation and through acceleration and
internationalization.
